Destiny Pharma
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sussex Innovation Centre Science Park Sq...Phone Number
+44 1273704440Website
www.destinypharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Destiny Pharma
Destiny Pharma is a clinical phase biotechnology company focused on developing novel anti-infectives aimed at infection prevention, particularly in the hospital market. The company is known for its lead asset, XF-73, which is designed to prevent post-surgical infections and has shown promising clinical data. Additionally, Destiny Pharma is working on a dermal formulation of XF-73 for treating bacterial skin infections, supported by the US National Institute for Allergy and Infectious Diseases. Their innovative XF drug platform offers an ultra-rapid mechanism to combat bacterial resistance, positioning them as leaders in infection prevention.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Destiny Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Destiny Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Destiny Pharma recently announced quarterly report
Product Launch: Get notified when Destiny Pharma launches new products
Check out if Destiny Pharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Destiny Pharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Destiny Pharma had a recent Job posting/layoffs
Destiny Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Destiny Pharma has new funding data
Recommended Actions
Reach out to Masked Content who joined Destiny Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Destiny Pharma
Compare insights from companies similar to Destiny Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Destiny Pharma
<$5M
11-50
Private
$24.5M
1997
N/A
Company Profile Activity
Activity Insights
Destiny Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Destiny Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Destiny Pharma.
Destiny Pharma financials insights
Gather financial insights about Destiny Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Unspecified
$4.7M
2017
Stock Offering
$19.8M
Destiny Pharma Tech Stack
A closer look at the technologies used by Destiny Pharma
See more technologies
Destiny Pharma News & Media
What Is The Ownership Structure Like For Destiny Pharma plc (LON:DEST)?
Every investor in Destiny Pharma plc ( LON:DEST ) should be aware of the most powerful shareholder groups. Generally...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Destiny Pharma
Sign Up For FreeTo access detailed company insights
Destiny Pharma is a clinical phase biotechnology company focused on developing novel anti-infectives aimed at infection prevention, particularly in the hospital market. The company is known for its lead asset, XF-73, which is designed to prevent post-surgical infections and has shown promising clinical data. Additionally, Destiny Pharma is working... Read More
